Brief: Heron Therapeutics Announces Filing Of Efficacy Supplement For Zynrelef And Provision In Newly Passed Congressional Bill

Heron Therapeutics

29/12/2022 15:30

Dec 29 (Reuters) - Heron Therapeutics Inc  HRTX.O :
    * HERON THERAPEUTICS ANNOUNCES FILING OF AN EFFICACY
SUPPLEMENT
FOR ZYNRELEF® AND PROVISION IN NEWLY PASSED CONGRESSIONAL BILL
ANTICIPATED TO PROVIDE SEPARATE REIMBURSEMENT OUTSIDE OF THE
PACKAGED SURGICAL PAYMENT FOR ZYNRELEF
    * HERON THERAPEUTICS INC- SUPPLEMENTAL NDA SUBMITTED
REQUESTING
EXPANSION OF INDICATION TO BROADLY COVER SOFT TISSUE AND
ORTHOPEDIC SURGICAL PROCEDURES
    * HERON THERAPEUTICS -OMNIBUS SPENDING BILL TO PROVIDE
SEPARATE
PAYMENTS FOR NON-OPIOID TREATMENT FOR PAIN RELIEF IN OUTPATIENT
SETTING FROM JAN 1, 2025

Source text for Eikon:  ID:nPn40WxCWa 
Further company coverage:  HRTX.O 
 ((reuters.briefs@thomsonreuters.com;))